0001493152-23-001331.txt : 20230112 0001493152-23-001331.hdr.sgml : 20230112 20230112190024 ACCESSION NUMBER: 0001493152-23-001331 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221114 FILED AS OF DATE: 20230112 DATE AS OF CHANGE: 20230112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gates Erica F. CENTRAL INDEX KEY: 0001885958 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40943 FILM NUMBER: 23526869 MAIL ADDRESS: STREET 1: C/O BIOFONTERA INC., STREET 2: 120 PRESIDENTIAL WAY, SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biofrontera Inc. CENTRAL INDEX KEY: 0001858685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473765675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-245-1325 MAIL ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 4 1 ownership.xml X0306 4 2022-11-14 1 0001858685 Biofrontera Inc. BFRI 0001885958 Gates Erica F. 120 PRESIDENTIAL WAY SUITE 330 WOBURN MA 01801 0 1 0 0 Senior Director Finance Following the appointment of Fred Leffler as Chief Financial Officer, the reporting person no longer serves as the principal accounting officer of the Company and the reporting person's policy making functions have changed such that she is no longer considered an "officer" for purposes of Section 16. The reporting person will continue in her role as Senior Director Finance, but will no longer be required to report transactions in equity securities of the registrant on Form 4 or Form 5. /s/ Daniel Hakansson, Attorney-in-fact for Erica F. Gates 2023-01-12